Inhibition of fatty acid metabolism by etomoxir or TOFA suppresses murine dendritic cell activation without affecting viability

References

• Merad M, Sathe P, Helft J, et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013;31:563–604.
   PubMed Web of Science ®Google Scholar
• Guilliams M, Ginhoux F, Jakubzick C, et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014;14:571–578.
   PubMed Web of Science ®Google Scholar
• Gallo PM, Gallucci S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front Immunol. 2013;4:138.
   PubMed Web of Science ®Google Scholar
• Ganguly D, Haak S, Sisirak V, et al. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013;13:566–577.
   PubMed Web of Science ®Google Scholar
• Quintana FJ. Dendritic cells in autoimmunity, infections, and cancer. Semin Immunopathol. 2017;39:97–98.
   PubMed Web of Science ®Google Scholar
• Mbongue J, Nicholas D, Firek A, et al. The role of dendritic cells in tissue-specific autoimmunity. J Immunol Res. 2014;2014:1.
   Web of Science ®Google Scholar
• Drakesmith H, Chain B, Beverley P. How can dendritic cells cause autoimmune disease? Immunol Today. 2000;21:214–217.
   PubMedGoogle Scholar
• Amodio G, Gregori S. Dendritic cells a double-edge sword in autoimmune responses. Front Immunol. 2012;3:233.
   PubMed Web of Science ®Google Scholar
• Hardin JA. Dendritic cells: potential triggers of autoimmunity and targets for therapy. Ann Rheum Dis. 2005;64:iv86–iv90.
   PubMed Web of Science ®Google Scholar
• Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol. 2014;192:5459–5468.
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Alm GV, Eloranta ML. Type I interferon and lupus. Curr Opin Rheumatol. 2009;21:471–477.
   PubMed Web of Science ®Google Scholar
• Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197:711–723.
   PubMed Web of Science ®Google Scholar
• Obermoser G, Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus. 2010;19:1012–1019.
   PubMed Web of Science ®Google Scholar
• Guiducci C, Gong M, Xu Z, et al. TLR recognition of self-nucleic acids hampers glucocorticoid activity in lupus. Nature. 2010;465:937–941.
   PubMed Web of Science ®Google Scholar
• Colonna L, Dinnall JA, Shivers DK, et al. Abnormal costimulatory phenotype and function of dendritic cells before and after the onset of severe murine lupus. Arthritis Res Ther. 2006;8:R49.
   PubMed Web of Science ®Google Scholar
• Sriram U, Varghese L, Bennett HL, et al. Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onset. J Immunol. 2012;189:80–91.
   PubMed Web of Science ®Google Scholar
• Lupus Foundation of America, Inc [Internet]. Fact sheet. 2001. Available from: https://www.lupus.org/resources/what-is-lupus.
   Google Scholar
• Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.
   PubMed Web of Science ®Google Scholar
• Dolgin E. Lupus in crisis: as failures pile up, clinicians call for new tools. Nat Biotechnol. 2019;37:7–8.
   PubMed Web of Science ®Google Scholar
• Perl A. Review: metabolic control of immune system activation in rheumatic diseases. Arthritis Rheumatol. 2017;69:2259–2270.
   PubMed Web of Science ®Google Scholar
• Geltink RIK, Kyle RL, Pearce EL. Unraveling the complex interplay between T cell metabolism and function. Annu Rev Immunol. 2018;36:461–488.
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213:15–23.
   PubMed Web of Science ®Google Scholar
• Yin Y, Choi SC, Xu Z, et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 2015;7:274ra18.
   PubMed Web of Science ®Google Scholar
• Wu D, Sanin DE, Everts B, et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity. 2016;44:1325–1336.
   PubMed Web of Science ®Google Scholar
• Everts B, Amiel E, van der Windt GJ, et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012;120:1422–1431.
   PubMed Web of Science ®Google Scholar
• Chakhtoura M, Chain RW, Sato PY, et al. Ethyl pyruvate modulates murine dendritic cell activation and survival through their immunometabolism. Front Immunol. 2019;10:30.
   PubMed Web of Science ®Google Scholar
• Pike LS, Smift AL, Croteau NJ, et al. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 2011;1807:726–734.
   PubMed Web of Science ®Google Scholar
• Guseva NV, Rokhlin OW, Glover RA, et al. TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status. Cancer Biol Ther. 2011;12:80–85.
   PubMed Web of Science ®Google Scholar
• Herber DL, Cao W, Nefedova Y, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med. 2010;16:880–886.
   PubMed Web of Science ®Google Scholar
• Gallo PM, Rapsinski GJ, Wilson RP, et al. Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity. Immunity. 2015;42:1171–1184.
   PubMed Web of Science ®Google Scholar
• Xu J, Lee MH, Chakhtoura M, et al. STAT2 is required for TLR-induced murine dendritic cell activation and cross-presentation. J Immunol. 2016;197:326–336.
   PubMed Web of Science ®Google Scholar
• Sriram U, Biswas C, Behrens EM, et al. IL-4 suppresses dendritic cell response to type I interferons. J Immunol. 2007;179:6446–6455.
   PubMed Web of Science ®Google Scholar
• Sriram U, Xu J, Chain RW, et al. IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells. PLoS One. 2014;9:e87668.
   PubMed Web of Science ®Google Scholar
• Shriver LP, Manchester M. Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci Rep. 2011;1:79.
   PubMed Web of Science ®Google Scholar
• Hossain F, Al-Khami AA, Wyczechowska D, et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies. Cancer Immunol Res. 2015;3:1236–1247.
   PubMed Web of Science ®Google Scholar
• Zhu J, Liu X, Xie C, et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest. 2005;115:1869–1878.
   PubMed Web of Science ®Google Scholar
• Ding D, Mehta H, McCune WJ, et al. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol. 2006;177:5878–5889.
   PubMed Web of Science ®Google Scholar
• Fransen JH, Vlag J, Ruben J, et al. The role of dendritic cells in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2010;12:207.
   PubMed Web of Science ®Google Scholar
• Abdel Galil SM, Ezzeldin N, El-Boshy ME. The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine. 2015;76:280–287.
   PubMed Web of Science ®Google Scholar
• Lee MH, Chakhtoura M, Sriram U, et al. Conventional DCs from male and female lupus-prone B6.NZM Sle1/Sle2/Sle3 mice express an IFN signature and have a higher immunometabolism that are enhanced by estrogen. J Immunol Res. 2018;2018:1.
   Google Scholar
• Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633–643.
   PubMed Web of Science ®Google Scholar
• Steinman RM. Linking innate to adaptive immunity through dendritic cells. Novartis Found Symp. 2006;279:101–109. discussion 109–113, 216–219.
   PubMedGoogle Scholar
• Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol. 2014;32:609–634.
   PubMed Web of Science ®Google Scholar
• Decker P, Kötter I, Klein R, et al. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology. 2006;45:1087–1095.
   PubMed Web of Science ®Google Scholar
• Brahmakshatriya V, Kuang Y, Devarajan P, et al. IL-6 production by TLR-activated APC broadly enhances aged cognate CD4 helper and B cell antibody responses in vivo. J Immunol. 2017;198:2819–2833.
   PubMed Web of Science ®Google Scholar
• Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:1.
   Google Scholar
• Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med. 2006;3:e491.
   PubMed Web of Science ®Google Scholar
• Andrade F, Akhter E, Fang H, et al. ABSTRACT NUMBER: 619 elevated plasma levels of CXCL2 and CXCL10 have distinct predictive value in systemic lupus erythematosus. Am Coll Rheumatol. 2012;64:619.
   Google Scholar
• Timmers S, Nabben M, Bosma M, et al. Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proc Natl Acad Sci USA. 2012;109:11711–11716.
   PubMed Web of Science ®Google Scholar
• Briant LJB, Dodd MS, Chibalina MV, et al. CPT1a-dependent long-chain fatty acid oxidation contributes to maintaining glucagon secretion from pancreatic islets. Cell Rep. 2018;23:3300–3311.
   PubMed Web of Science ®Google Scholar
• Ibitokou SA, Dillon BE, Sinha M, et al. Early inhibition of fatty acid synthesis reduces generation of memory precursor effector T cells in chronic infection. J Immunol. 2018;200:643–656.
   PubMedGoogle Scholar
• Van den Bossche J, van der Windt GJW. Fatty acid oxidation in macrophages and T cells: time for reassessment? Cell Metab. 2018;28:538–540.
   PubMed Web of Science ®Google Scholar
• van der Windt GJ, Everts B, Chang CH, et al. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity. 2012;36:68–78.
   PubMed Web of Science ®Google Scholar
• Divakaruni AS, Hsieh WY, Minarrieta L, et al. Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab. 2018;28:490.e7–503.e7.
   Web of Science ®Google Scholar
• Samudio I, Harmancey R, Fiegl M, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120:142–156.
   PubMed Web of Science ®Google Scholar